Local Institution - 151
Surquillo, Lima region, Peru
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Heart Failure With Preserved Ejection Fraction
Edgewise Therapeutics, Inc.90 enrolledNCT07795814
Recruiting
Phase 2
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
Metastatic CancerAdvanced CancerMalignant Neoplasm of Lung
Mirati Therapeutics Inc.200 enrolled120 locationsNCT05853575